Carlson Capital L P Iovance Biotherapeutics, Inc. Transaction History

Carlson Capital L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $16,898 - $33,454	3,806 Added 3.64%	108,280 $492,000
Q2 2023 Aug 10, 2023	SELL	$5.36 - $9.06 $416,123 - $703,373	-77,635 Reduced 42.63%	104,474 $735,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $39,952 - $71,090	7,109 Added 4.06%	182,109 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $238,249 - $327,750	25,000 Added 16.67%	175,000 $1.68 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $319,000 - $916,499	50,000 Added 50.0%	150,000 $1.66 Million
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $1.24 Million - $1.91 Million	100,000 New	100,000 $1.67 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.